Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 4, 2012, Pages 1017-1023

  Liu, Hui ^a   Zhang, Xu ^a   Vinogradskiy, Yevgeniy Y ^a   Swisher, Stephen G ^a   Komaki, Ritsuko ^a   Chang, Joe Y ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DISEASE CONTROL; ELECTROPHYSIOLOGY; MULTIVARIANT ANALYSIS; PATIENT TREATMENT; RADIATION; REGRESSION ANALYSIS;

EASTERN COOPERATIVE ONCOLOGY GROUP; FORCED EXPIRATORY VOLUME IN 1; FRACTIONATED RADIATION; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSIONS; PLANNING TARGET VOLUMES; RADIATION PNEUMONITIS;

RADIOTHERAPY;

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SIZE; DISEASE SEVERITY; DISTANT METASTASIS; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INCIDENCE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RISK FACTOR; SCORING SYSTEM; STEREOTACTIC BODY RADIATION THERAPY; THORAX; TREATMENT PLANNING; TREATMENT RESPONSE; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; RADIATION DOSE; RADIOSURGERY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION PNEUMONITIS; RADIOSURGERY; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84872005539     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.020     Document Type: Article

References (17)

1. Chang JY, Dong L, Liu H, et al. Image-guided radiation therapy for non-small cell lung cancer. J Thorac Oncol 2008; 3: 177-186.
2. Blackstock AW, Govindan R. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer. J Clin Oncol 2007; 25: 4146-4152.
3. Jeremic B, Shibamoto Y, Acimovic L, et al. Second cancers occurring in patients with early stage non-small cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 2001; 19: 1056-1063.
4. Fraumeni JF Jr., Curtis RE, Edwards BK, et al. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. In: Curtis RE, Freedman DM, Ron E, et al., editors. Bethesda, MD: National Cancer Institute; 2006. p. 1-7.
5. Kramer GWPM, Gans S, Ullmann E, et al. Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment? Int J Radiat Oncol Biol Phys 2004; 58: 1388-1393.
6. Tada T, Fukuda H, Matsui K, et al. Non-small-cell lung cancer: reir-radiation for loco-regional relapse previously treated with radiation therapy. Int J Clin Oncol 2004; 10: 247-250.
7. Okamoto Y, Murakami M, Yoden E, et al. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys 2002; 52: 390-396.
8. Socinski MA, Shcell MJ, Bakri K, et al. Second-line, low-dose, weekly paclitaxel in patients with stage III/A/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. Cancer 2002; 95: 1265-1273.
9. Gonzalez CM, Aramendia JM, Salgado E, et al. Second-line chemotherapy with irinotecan and vinorelbine in stage IIIB and IV non-small-cell lung cancer: a phase II study. Am J Clin Oncol 2002; 25: 480-484.
10. Serke M, Schoenfeld N, Loddenkemper R, et al. Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: phase II trial. Anticancer Res 2004; 24: 1211-1216.
11. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-1076.
12. Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapyinmultiple organ sites. J Clin Oncol 2007; 25: 947-952.
13. Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 72: 967-971.
14. Loo BW, Chang JY, Dawson L, et al. Stereotactic ablative radiotherapy: what's in a name? Practical Radiat Oncol 2011; 1: 38-39.
15. Kelly P, Balter PA, Rebueno N, et al. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys 2010; 78: 1387-1393.
16. Hayakawa K, Mitsuhashi N, Saito Y, et al. Short communication: adverse chronic effects of high-dose irradiation on proximal bronchus in patients treated for bronchogenic carcinoma. Br J Radiol 1993; 66: 477-479.
17. Wennberg BM, Baumann P, Gaqliardi G, et al. NTCP modeling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction. Acta Oncol 2011; 50: 518-527.